McIlrath & Eck’s Boston Scientific BSX Stock Holding History

McIlrath & Eck’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.83K	Hold	77	–	–	﹤0.01%	1232
2025 Q4	$7.34K	Hold	77	–	–	﹤0.01%	714
2025 Q3	$7.52K	Hold	77	–	–	﹤0.01%	684
2025 Q2	$8.27K	Hold	77	–	–	﹤0.01%	626
2025 Q1	$7.77K	Hold	77	–	–	﹤0.01%	644
2024 Q4	$6.88K	Hold	77	–	–	﹤0.01%	690
2024 Q3	$6.45K	Hold	77	–	–	﹤0.01%	706
2024 Q2	$5.93K	Hold	77	–	–	﹤0.01%	688
2024 Q1	$5.27K	Hold	77	–	–	﹤0.01%	712
2023 Q4	$4.45K	Hold	77	–	–	﹤0.01%	694
2023 Q3	$4.07K	Hold	77	–	–	﹤0.01%	693
2023 Q2	$4.17K	Hold	77	–	–	﹤0.01%	706
2023 Q1	$3.85K	Buy	+77	New	+$3.63K	﹤0.01%	707
2021 Q4	–	Sell	-373	Closed	-$16K	–	798
2021 Q3	$16K	Hold	373	–	–	﹤0.01%	434
2021 Q2	$16K	Hold	373	–	–	﹤0.01%	428
2021 Q1	$14K	Buy	+373	New	+$14.1K	﹤0.01%	413

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

McIlrath & Eck's BSX Position: Q1 2026 in Review

McIlrath & Eck held its Boston Scientific (BSX) position steady in Q1 2026 at 77 shares worth $4.83K. The position accounts for ﹤0.01% of the portfolio, ranked #1232.

McIlrath & Eck first reported a position in BSX in Q1 2021 and has held it in 16 quarters since. The position peaked at $16K in Q3 2021. 1,676 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

McIlrath & Eck held 77 shares of Boston Scientific worth $4.83K as of Q1 2026.
McIlrath & Eck left its Boston Scientific share count unchanged in Q1 2026.
Boston Scientific made up ﹤0.01% of McIlrath & Eck's portfolio in Q1 2026, its #1232 holding.
McIlrath & Eck first reported a position in Boston Scientific in Q1 2021 and has held it in 16 quarters since.
McIlrath & Eck's Boston Scientific position peaked at $16K in Q3 2021.
1,676 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on McIlrath & Eck's 13F filing for Q1 2026, filed 19 May 2026.